The Pharmaceutical Development of Inhalation Medicines and the Value of Outsourcing
News
Article
Pharmaceutical TechnologyPharmaceutical Technology-05-02-2002
Volume 26
Issue 5
A knowledgeable and experienced contract service provider can help in the development and success of an inhalation drug product.
Articles in this issue
Direct Compression: Microcrystalline Cellulose Grade 12 versus Classic Grade 102
Harmonizing Standards and Specifications
Polymers in Transdermal Drug Delivery Systems
The Pharmaceutical Development of Inhalation Medicines and the Value of Outsourcing
Expanding the Use of Child-Resistant Packaging
Forced Degradation of Ibuprofen in Bulk Drug and Tablets and Determination of Specificity, Selectivity, and the Stability-Indicating Nature of the USP Ibuprofen Assay Method
Outsourcing Outlook
Analytical Data Management and Archiving: 21 CFR Part 11 Compliance and Beyond
E-Procurement — Reverse Auctions and the Supplier's Perspective
Recent Videos
Related Content
Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025
March 17th 2025Article
This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024Podcast
In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
